Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Allergopharma Logo
Allergopharma Growth Score
79
CB Rank
1810643
Heat Score
33
Allergopharma is in allergen-specific immunotherapy of type 1 allergies such as hay fever or allergic asthma.
Acquired by
Dermapharm Logo
Dermapharm
Private Reinbek, Schleswig-Holstein, Germany www.allergopharma.com/
Health Care
Overview

Allergopharma
Growth Score
79
Heat Score
33

Growth Score79
-7 pts
in past quarter
Heat Score 33
-8 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Allergopharma

CB Rank
1810643
Allergopharma is in allergen-specific immunotherapy of type 1 allergies such as hay fever or allergic asthma.
Acquired by
Dermapharm Logo
Dermapharm
Private Reinbek, Schleswig-Holstein, Germany www.allergopharma.com/
Health Care

Details

Operating Status Active
Company Type For Profit
About the Company
Allergopharma is in allergen-specific immunotherapy of type 1 allergies such as hay fever or allergic asthma.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Allergen Diagnostics
Diagnostic products for identifying type 1 allergies through prick and provocation testing methods.
Subcutaneous Allergen Immunotherapy Preparations
Therapeutic preparations for subcutaneous allergen immunotherapy to treat IgE-mediated allergic diseases.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

M&A Details

Allergopharma was acquired by Dermapharm on
obfuscation
.
Transaction Name 
Allergopharma acquired by Dermapharm Logo
Allergopharma acquired by Dermapharm
Acquired by 
Dermapharm Logo
Dermapharm
Announced Date 
obfuscation
Market Intelligence
People
View Profiles & Contacts
Contacts 1
News

News and Press

News•May 26, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 27, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$972KThis year, Allergopharma is projected to spend $972K on IT, according to Aberdeen.

Active Website Tech Count

23Allergopharma is actively using 23 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, HSTS, and  DNSSEC.

Total IP

50Allergopharma has registered 50 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Allergopharma's headquarters? Allergopharma is located in Reinbek, Schleswig-Holstein, Germany.Who are Allergopharma's competitors? Alternatives and possible competitors to Allergopharma may include DBV Technologies, ALK, and  Allergopharma Joachim Ganzer.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|